Enveric Biosciences appoints Frank Pasqualone to Board, effective July 13, 2022

Enveric Biosciences, Inc.

Frank Pasqualone appointed to board, filling vacancy from size increase from 8 to 9 directors.
Term expires at 2022 annual meeting; successor to be elected or until earlier resignation.
No arrangements with any person or reportable transactions under Item 404(a).

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Frank Pasqualone

Director

ENVB · Enveric Biosciences, Inc.

Effective: 2022-07-13
Filed: July 18, 2022, 7:59 PM ET

On July 13, 2022, Frank Pasqualone was appointed to the board of directors (the “Board”) of Enveric Biosciences, Inc. (the “Company”), to serve as a director of the Board, to fill a vacancy as a result of the increase in the size of the Board from eight to nine persons, effective as of the same date

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Frank Pasqualone was appointed as Director at Enveric Biosciences, Inc..

Action: appointed
Role: Director

Exact text from the filing

On July 13, 2022, Frank Pasqualone was appointed to the board of directors (the “Board”) of Enveric Biosciences, Inc. (the “Company”), to serve as a director of the Board, to fill a vacancy as a result of the increase in the size of the Board from eight to nine persons, effective as of the same date

View on SEC.gov

Enveric Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-019579

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.